BioLife Solutions has executed a successful turnaround by refocusing on core products and divesting non-core assets. Read ...
BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results